Medications

New drug combinations found for resistant cancers

Sanger researchers have created the world's largest novel resource using systematic drug testing and genetics analyses to show new potential drug combinations for breast, colon, and pancreatic cancer.

Oncology & Cancer

Tailoring lung cancer therapies to individual patients

Recent findings in the laboratory of University of Kentucky Markey Cancer Center researcher Christine Brainson, Ph.D., could lead to promising treatments for two molecular subtypes of lung cancer.

Medications

Promising results of Phase 1 drug trial for HIV patients

A Phase 1 clinical trial conducted by University of Minnesota researchers has demonstrated the safety and efficacy of a novel immunotherapy drug in the treatment of human immunodeficiency virus (HIV). Results of the trial ...

page 29 from 40